Pure Global's MedTech Guide: Mastering Brazil's ANVISA RDC 497/2021 for Your Device Registration and GMP Certification Update episode artwork

EPISODE · Sep 24, 2025 · 3 MIN

Pure Global's MedTech Guide: Mastering Brazil's ANVISA RDC 497/2021 for Your Device Registration and GMP Certification Update

from LATAM MedTech Insights

In this episode of LATAM MedTech Insights, we dissect the crucial updates to Brazil's medical device regulations, specifically ANVISA's RDC 497/2021 and the recent amendment RDC 850/2024. We explore how these resolutions have fundamentally changed the administrative process for obtaining and renewing the essential Brazilian Good Manufacturing Practice (B-GMP) certificate. We uncover why the recent extension of B-GMP validity from two to four years makes a flawless submission more critical than ever. We'll walk you through a real-world case study of a diagnostic device manufacturer that faced a three-month market lockout due to minor administrative errors in their renewal application, highlighting the costly pitfalls of navigating these new standardized procedures without expert local knowledge. Key questions answered in this episode: 1. What is the true impact of RDC 497/2021 on my existing Brazilian device registration? 2. How did the recent RDC 850/2024 amendment change the game for B-GMP certificate renewals? 3. What are the most common and costly administrative pitfalls when submitting documents to ANVISA's Solicita system? 4. Why is a simple document codification error now enough to get my entire submission rejected? 5. How far in advance should I begin my B-GMP renewal process to avoid market disruption? 6. What specific steps can I take to ensure my technical dossier is compliant with the latest requirements? 7. How can I turn these regulatory updates into a strategic advantage for my company in Brazil? At Pure Global, we transform regulatory complexity into market access. Our team of local experts, powered by advanced AI tools, offers end-to-end solutions for MedTech and IVD companies in over 30 markets, including Brazil. From initial strategy to post-market surveillance, we act as your local representative to ensure your products reach the market efficiently and remain compliant. Don't let administrative hurdles block your growth in Latin America. Contact us at [email protected] or visit https://pureglobal.com/ to learn more.

Episode metadata supplied by the publisher feed · Published Sep 24, 2025

Embed this episode

NOW PLAYING

Pure Global's MedTech Guide: Mastering Brazil's ANVISA RDC 497/2021 for Your Device Registration and GMP Certification Update

0:00 3:32

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of LATAM MedTech Insights?

This episode is 3 minutes long.

When was this LATAM MedTech Insights episode published?

This episode was published on September 24, 2025.

Can I download this LATAM MedTech Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!